Compounds for the treatment of metabolic disorders

Details for Australian Patent Application No. 2007208125 (hide)

Owner Wellstat Therapeutics Corporation

Inventors Sharma, Shalini; Von Borstel, Reid W.

Agent FB Rice

Pub. Number AU-B-2007208125

PCT Pub. Number WO2007/087504

Priority 60/762,066 25.01.06 US

Filing date 22 January 2007

Wipo publication date 2 August 2007

Acceptance publication date 5 April 2012

International Classifications

C07D 303/48 (2006.01) Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom

A01N 35/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical

A61K 31/12 (2006.01) - Ketones

Event Publications

17 July 2008 PCT application entered the National Phase

  PCT publication WO2007/087504 Priority application(s): WO2007/087504

5 April 2012 Application Accepted

  Published as AU-B-2007208125

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007208127-Compounds for the treatment of metabolic disorders

2007208112-Termination assessment of a computer simulation